Company intelligence / Profile preview

Wound Care Technologies

Minnesota, United States

Ownership: Private
Development stage: Other

Overview

A device-based platform (Dermaclose) for chronic and post-surgical wound closure, including fasciotomy wounds. One prospective, observational investigator-initiated clinical trial for fasciotomy wound closure was terminated (NCT01171534), but the Dermaclose device remains marketed for chronic and complex wound management[4].

Therapeutic areas: OtherDermatology
Modalities: Device
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on Wound Care Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Wound Care Technologies.

Explore the full profile